Beneficial effects of a vanadium complex with cysteine, administered at low doses on benzo(α) pyrene-induced leiomyosarcomas in wistar rats

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3609-3613

  Liasko, Roman ^a   Kabanos, Themistoclis A ^a   Karkabounas, Spiros ^a   Malamas, Michael ^a   Tasiopoulos, Anastasios J ^a   Stefanou, Dimitris ^a   Collery, Philippe ^b   Evangelou, Angelos ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Inst Intl Rech Ions Metalliques   (France)

Author keywords

Benzo( )pyrene; Cysteine; Leiomyosarcomas; Vanadium; Vanadium (III) cysteine complex; Vanadyl sulfate; Wistar rats

Indexed keywords

BENZO[A]PYRENE; CYSTEINE; VANADIUM DERIVATIVE; VANADYL SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; HISTOPATHOLOGY; LEIOMYOSARCOMA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TUMOR GROWTH; TUMOR REGRESSION;

ANIMALS; ANTICARCINOGENIC AGENTS; BENZO(A)PYRENE; CARCINOGENS; CYSTEINE; DRUG COMBINATIONS; DRUG SCREENING ASSAYS, ANTITUMOR; LEIOMYOSARCOMA; MALE; RATS; RATS, WISTAR; VANADIUM COMPOUNDS;

EID: 0031731288     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tomson JH,Chasteen ND and Meeker LD: Dietary vanadyl(IV) sulfate inhibits chemically-induced mammary carcinogenesis. Carcinogenesis 5: 849-851, 1984.
2. Bishayee A, Chatterjee RM: Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital. Br J Cancer 71: 1214-1220, 1995.
3. Bishayee A, Chatterjee RM: Inhibition of altered liver cell foci and persistent nodule growth by vanadate during diethylnitrosamine-induced hepatocarcinogenesis in rats. Anticancer Res 15: 455-461, 1995.
4. Kopf-Maier P and Kopf H: Vanadocen dichloride-another antitumor agent from the metallocene series. Z. Natuforsch 84b: 805-807, 1979.
5. Cruz TP ,Morgan A, Min W: Antineoplastic effects of vanadium compounds. Proc Annu Meet Am Assoc Cancer Res 36: A2357, 1995.
6. Djorgevitz C: Antitumor activity of vanadium compounds. In: Siegel H and Siegel A, eds, Metal Ions in Biological Systems, Marcel-Decker, N.Y, 31: 596-616, 1995.
7. Moebious VJ, Stein R, Kieback DG, Runnebaum IB, Sass G and Freinberg R: Antitumor activity of new organometallic compounds in human ovarian cancer cell lines in comparison to platin derivatives. Anticancer Res 17: 815-822, 1997.
8. Evangelou A, Karkabounas S, Kalpouzos G, Malamas M, Liasko R, Stefanou D, Vlahos AT, Kabanos TA: Comparison of the therapeutic effects of two vanadium complexes, administered at low doses on benzo(α)pyrene- induced malignant tumors in rats. Cancer Lett 119: 221-225, 1997.
9. Kallistratos G, Evangelou A, Agnantis N, Fasske E, Karkabounas S, Donos A: Enhancement of the antineoplastic effect of anticarcinogens on Benzo(a)pyrene-treated rats,in relation to their number and biological activity. Cancer Lett 82: 153-165, 1994.
10. Kalpouzos G: Antioxidant's effects, on experimental chemical carcinogenesis. Thesis, Medical Faculty, University of Ioannina, Greece. 1996.
11. Carpenter G : Vanadate, epidermal growth factor and the stimulation of DNA synthesis. Biochem Biophys Res Commun 102: 1115-1121, 1981.
12. Hori C,and Oka T: Vanadate enhances the stimulatory action of insulin on DNA synthesis in cultured mouse mammary glands. Biochem Biophys Acta 610: 235-240, 1980.
13. Jandhyala BS,and Horn GJ: Minireview: Physiological and pharmacological effects of vanadium. Life Sci 33: 1325-1340 ,1983.
14. Kustin K and Macara JG: The new biochemistry of vanadium. Comments Inorg Chem 102: 1-72, 1982.
15. Iwai K, Kimura S, Ido T, Iwata R: Tumor uptake of vanadium-48, vanadyl chlorine E-6 sodium, as a tumor imaging agent,in tumor bearing mice. Nuclear Med Biol 117: 775-780, 1980.
16. Sadar S, Mondal A, Chatergjee M: Protective role of co-vanadium in the survival of hosts during the growth of a transplantable murine lymphoma and its profound effects on the rates and patterns of biotransformation. Neoplasma 40: 27-30, 1993.
17. Ramanadham S, Mongold J-J, Brownsey RW, Cros GH and McNeil JH: Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am J Physiol 257: H904-H911, 1989.